BioSpace News Archive

Pharm Country

Universal Display Corporation Announces Participation at Upcoming January 2020 Conferences

Universal Display Corporation announced its participation in the following investor and industry conferences.

January 6, 2020
·
3 min read
Policy

MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors

The MEDICREA® Group announced that the United States Patent Office has recently issued the Company 7 additional key patents related to the UNiD™ ASI proprietary technology platform.

January 6, 2020
·
4 min read
BioCapital

NextCure to Present at the 38th Annual J.P. Morgan Healthcare Conference

NextCure, Inc. announced that the company will present at the 38th Annual J.P. Morgan Healthcare Conference being held January 13-16, 2020, in San Francisco, California.

January 6, 2020
·
2 min read
Deals

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock - Jan. 06, 2020

Intra-Cellular Therapies, Inc., a biopharmaceutical company, announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock.

January 6, 2020
·
2 min read
BioMidwest

Centene To Present At 38th Annual J.P. Morgan Healthcare Conference

Centene Corporation announced it will present at the 38th Annual J.P. Morgan Healthcare Conference, to be held at the Westin St. Francis Hotel in San Francisco, January 13-16, 2020.

January 6, 2020
·
2 min read
Policy

Lyra Therapeutics Announces FDA Clearance of Investigational New Drug Application for a Phase 2 Clinical Trial of LYR-210 for Chronic Rhinosinusitis

Lyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration has cleared the company’s Investigational New Drug application for LYR-210 for the treatment of chronic rhinosinusitis, a debilitating chronic disease affecting millions of patients.

January 6, 2020
·
3 min read
Pharm Country

Bristol-Myers Squibb to Present at the 38th Annual J.P. Morgan Healthcare Conference

Bristol-Myers Squibb Company will present at the J.P. Morgan 38th Annual Healthcare Conference on Monday, January 13, 2020 in San Francisco.

January 6, 2020
·
1 min read
Business

Mirati Therapeutics Announces Executive Management Changes

Appoints Dan Faga, Chief Operating Officer and Ben Hickey, Chief Commercial Officer

January 6, 2020
·
9 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Phase 3 KEYNOTE-604 Study Did Not Meet Other Dual Primary Endpoint of Overall Survival; Results to be Presented at Upcoming Medical Meeting

January 6, 2020
·
30 min read
Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2019-2023 | Evolving Opportunities with AstraZeneca and Boehringer Ingelheim | Technavio

Technavio announced its latest market research report titled global chronic obstructive pulmonary disease (COPD) drugs market 2019-2023

January 6, 2020
·
5 min read